Results 161 to 170 of about 305,628 (395)

Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Coronary slow flow (SF) and no‐reflow (NR) are clinically significant complications of percutaneous coronary intervention (PCI), particularly in ST‐segment elevation myocardial infarction (STEMI) and saphenous vein graft (SVG) interventions. Angiographically defined as impaired myocardial perfusion despite restored epicardial patency, SF/NR ...
Bharat Khialani   +5 more
wiley   +1 more source

Thrombophlebitis (superficial veins thrombosis): modern standards of diagnostics and therapy

open access: yesАмбулаторная хирургия, 2016
Thrombophlebitis (inflammation and thrombosis of superficial veins of any localization) is a frequent pathologic state. In the special literature they use notions varicothrom-bophlebitis for designation of thrombosis and inflammation of the varicose vein
V. Y. Bogachev   +3 more
doaj  

Perbandingan Pemberian Heparin Subkutan Dan Intravena Terhadap Kadar Fibrinogen Pada Pencegahan Deep Vein Thrombosis [PDF]

open access: yes, 2012
Background: Deep vein thrombosis (DVT) is a condition where thrombus is formed in a deep vein especially in the lower limbs and inguinal. Blood clots can obstruct blood flow from lower limbs to the heart.
Rangga, V. (Valentino)   +1 more
core  

Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels

open access: yesThrombosis Research, 2020
P. Demelo-Rodríguez   +13 more
semanticscholar   +1 more source

Recanalization of Thrombosed Atrial Flow Regulator in Failing Fontan: A Bridge to Transplant

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We report the case of a 10‐year‐old boy (41 kg, 133 cm) with hypoplastic left heart syndrome (mitral and aortic atresia), who underwent staged palliation: Norwood‐Sano at 6 days, Glenn at 7 months, and Fontan completion at 3 years using a 16 mm non‐fenestrated extracardiac Gore‐Tex conduit.
Raymond N. Haddad   +3 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

open access: yesArchives of Internal Medicine, 2000
J. Heit   +6 more
semanticscholar   +1 more source

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Complement activation assessed by C3bc and C5b-9 terminal complex as diagnostic biomarkers for deep vein thrombosis.

open access: yesPLoS ONE
BackgroundThe overuse of compression ultrasound procedures on patients with suspected deep vein thrombosis compromise the cost-effectiveness of deep vein thrombosis management and emphasize room for improvement of the current diagnostic algorithm. As the
Vårin Eiriksdatter Wikan   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy